期刊文献+

巨淋巴结增生症的临床特点及外科治疗 被引量:3

原文传递
导出
摘要 目的探讨巨淋巴结增生症(castleman’s disease,CD)的临床特点及外科治疗方法。方法分析2005年10月至2010年3月首都医科大学附属北京友谊医院收治9例巨淋巴结增生症患者的临床资料,其中男7例、女2例,平均年龄51.8岁。出现临床症状2例,包括咳嗽、胸闷、发热、乏力、盗汗等,其他为体检发现。9例患者术前均行胸部X线片、胸部CT、单光子发射计算机断层成像术(SPECT)和腹部B超检查。接受手术切除治疗。结果在临床分型中,单中心型CD 5例,多中心型CD 4例;病理分型中,透明血管型6例,浆细胞型1例,混合型2例。由于瘤体血供丰富,术中出血较多,平均出血量514.4 ml,最多2 500 ml。5例单中心型CD患者均生存,无复发;多中心型CD 4例,随访3~5年,4例均生存,其中2例分别于术后1年、3年后复发,再次行手术切除,术后病理结果与第1次手术相同。结论 CD的诊断主要依靠影像及病理学,而最后确诊还应以病理学为准。无论哪种类型的CD外科切除均为有效的治疗方法,单中心型CD手术切除病变可达到彻底治愈的目的,而多中心型CD手术切除后仍有复发可能,应适当联合化疗、放疗等其他治疗手段。
出处 《中国胸心血管外科临床杂志》 CAS 2013年第2期232-234,共3页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
  • 相关文献

参考文献17

  • 1Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 1956, 9 (4) :822-830.
  • 2Frizzra G. Castleman's disease and related disorders. Semin Diagno Pathol, 1988, 5(4): 346-351.
  • 3S.hahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc, 1995, 70 (10) : 969-977.
  • 4Seo HY, Kim EB, Kim JW, et al. Complete remission in a patient with human herpes virus-8 negative multicentric Castleman disease using CHOP chemotherapy. Cancer Res Treat, 2009, 41 (2) : 104-107.
  • 5Sato N, Kondo S, Saito K, et al. Hyaline vascular-type Castleman's disease in the hepatoduodenal ligament: report of a case. Surg Today, 2006, 36 (7) : 647-650.
  • 6Luppi M, Barozzi P, Maiorana A, et al. Human herpevirus-8 DNA sequences in human immunodeficieney virus-negative angioimmu- noblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood, 1996, 87(9): 3903.
  • 7Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol, 2005, 129(1): 3-17.
  • 8Bowne WB, Lewis J J, Filippa DA, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer, 1999, 85 ( 3 ) : 706-717.
  • 9Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer, 2001, 92 (3): 670-676.
  • 10Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med, 1998, 128 (8). 657-662.

二级参考文献16

  • 1Sharma R, Seth R, Thavaraj V. Multicentric Castleman's disease in two cases[J]. Indian J Pediatr, 2007,74 (12):1116.
  • 2Bower M,Powles T, Williams S, et al. Brief communication:rituximab in HIV-associated multicentric Castleman disease[J]. Ann Intern Med,2007,147(12) ..836.
  • 3Bestawros A, Michel R, Sfguin C, et al. Multicentric Castlemanrs disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series[J].Am J Hematol,2008,83(6) :508.
  • 4Gerard L, Berezne A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial[J].J Clin Oncol, 2007, 25(22) :3350.
  • 5Dham A, Peterson BA. Castleman disease[J].Curr Opin Hematol,2007,14(4) : 354.
  • 6Kenyon C, Pillay K,Jacobs P. Castleman's disease and retroviral therapy[J].Transfus Apher Sei, 2007,37 (1) : 81.
  • 7Iagaru A, Mari C, Sam Gambhir S. Follicular dendritic sarcoma within a focus of Castleman' s disease. Serial FDG PET/CT in the follow up of recurrence with histopathologie confirmation[J]. Rev Esp Med Nucl, 2007, 26(1) :40.
  • 8Castleman B,Iverson L,Menendez VP.Localized mediastinal lymphnode hyperplasia resembling thymoma.Cancer,1956,9:822
  • 9Keller AR,Hochholzer L,Castleman B.Hyaline-Vasular and plasmaceel types of giant lymph node hyperplasia of the mediastinum and other locations.Cancer,1972,29(3):670
  • 10Bowne WB,Lewis JJ,Filippa DA et al.The management of unicentric and multicentric Castleman's disease:a report of 16 cases and a review of the literature.Cancer,1999,85(3):706

共引文献3

同被引文献17

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部